RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis

par Kruszewski, Adam M., Rao, Gautam, Tatomir, Alexandru, Hewes, Daniel, Tegla, Cosmin A., Cudrici, Cornelia D., Nguyen, Vingh, Royal, Walter, Bever, Christopher T., Rus, Violeta, Rus, Horea
Publié dans Exp Mol Pathol (2015)

Epigenetic modifications induced by RGC-32 in colon cancer

par Vlaicu, Sonia I., Tegla, Cosmin A., Cudrici, Cornelia D., Fosbrink, Matthew, Nguyen, Vingh, Azimzadeh, Philippe, Rus, Violeta, Chen, Hegang, Mircea, Petru A., Shamsuddin, Abulkalam, Rus, Horea
Publié 2009